Nosis Bio CEO to lead panel discussion at California Life Sciences Summit on the Power of AI in Pharma R&D

We’re excited to announce that Jim Martineau, CEO of Nosis Bio will be leading an insightful panel discussion, Decoding Drug Discovery, at the upcoming West Coast Summit: The Transformative Power of AI in Pharmaceutical R&D on October 3, 2024, in South San Francisco. Organized by California Life Sciences, the summit brings together industry leaders to discuss the latest advances in artificial intelligence and its groundbreaking applications in drug discovery and development.

As a leader in AI-enabled therapeutics design and development, Nosis Bio brings expertise in the integration of AI-driven methods with drug design, focusing on physics-aware deep learning, generative AI, and the development of precision-targeted genetic medicines. This discussion will explore how AI is reshaping the way we discover, design, and develop therapeutics, ultimately aiming to improve the success rates of clinical trials and bring more effective medicines to patients faster.

Joining the panel will be other experts in biotech, machine learning, and drug development, making this a must-attend session for anyone interested in the transformative role of AI in healthcare innovation.

For more information, visit the California Life Sciences event page.

‍